Clinical Trial Update: Healthy Volunteer Pilot Study Using 3 Types of Modified Release Formulations of Firategrast to Investigate How Quickly Absorption From the Digestive System Takes Place. [Phase 1]

View source ↗

Summary

Phase 1 healthy volunteer study evaluating three modified-release formulations of firategrast to assess how quickly the drug is absorbed from the digestive syst…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Firategrast (Firategrast)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 1 | Status: COMPLETED